Danaparoid
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Danaparoid, covering 2022-12-08 to 2024-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels